Vor strengthens leadership team with addition of dr. veit schmelmer as svp of program and alliance management

Cambridge, mass., oct. 12, 2021 (globe newswire) -- vor biopharma (nasdaq: vor), a clinical-stage cell and genome engineering company, today announced the appointment of veit schmelmer, ph.d., as vor's senior vice president of program and alliance management. dr. schmelmer has more than 25 years of experience leading the development of novel therapies for cancer, autoimmune disorders and infectious diseases at leading biopharmaceutical companies.
VOR Ratings Summary
VOR Quant Ranking